25 XP   0   0   10

CorMedix Inc
Buy, Hold or Sell?

Let's analyse Cormedix together

PenkeI guess you are interested in CorMedix Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of CorMedix Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about CorMedix Inc

I send you an email if I find something interesting about CorMedix Inc.

Quick analysis of Cormedix (30 sec.)










What can you expect buying and holding a share of Cormedix? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
2.5%

What is your share worth?

Current worth
$1.28
Expected worth in 1 year
$1.55
How sure are you?
35.0%

+ What do you gain per year?

Total Gains per Share
$0.27
Return On Investment
5.2%

For what price can you sell your share?

Current Price per Share
$5.28
Expected price per share
$4.4 - $8.025
How sure are you?
50%

1. Valuation of Cormedix (5 min.)




Live pricePrice per Share (EOD)

$5.28

Intrinsic Value Per Share

$-8.17 - $-6.48

Total Value Per Share

$-6.89 - $-5.21

2. Growth of Cormedix (5 min.)




Is Cormedix growing?

Current yearPrevious yearGrowGrow %
How rich?$70.1m$58.2m$5.8m9.1%

How much money is Cormedix making?

Current yearPrevious yearGrowGrow %
Making money$98.7m-$7.3m$106m107.4%
Net Profit Margin0.0%-63,476.8%--

How much money comes from the company's main activities?

3. Financial Health of Cormedix (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#436 / 1016

Most Revenue
#979 / 1016

Most Profit
#30 / 1016

Most Efficient
#311 / 1016

What can you expect buying and holding a share of Cormedix? (5 min.)

Welcome investor! Cormedix's management wants to use your money to grow the business. In return you get a share of Cormedix.

What can you expect buying and holding a share of Cormedix?

First you should know what it really means to hold a share of Cormedix. And how you can make/lose money.

Speculation

The Price per Share of Cormedix is $5.28. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cormedix.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cormedix, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.28. Based on the TTM, the Book Value Change Per Share is $0.07 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.04 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cormedix.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.27-5.1%-0.21-4.0%-0.14-2.6%-0.15-2.9%-0.13-2.5%
Usd Book Value Change Per Share-0.20-3.7%0.071.3%-0.04-0.7%0.061.1%0.030.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.20-3.7%0.071.3%-0.04-0.7%0.061.1%0.030.6%
Usd Price Per Share3.76-3.89-4.14-5.68-3.85-
Price to Earnings Ratio-3.50--4.77--7.68--19.48--11.80-
Price-to-Total Gains Ratio-19.24--64.66--49.65--407.30--199.59-
Price to Book Ratio2.95-3.53-3.90-9.32-6.80-
Price-to-Total Gains Ratio-19.24--64.66--49.65--407.30--199.59-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share5.28
Number of shares189
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.070.06
Usd Total Gains Per Share0.070.06
Gains per Quarter (189 shares)12.9611.21
Gains per Year (189 shares)51.8544.83
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10524204535
201049409080
301561460134125
402071980179170
502592500224215
603113020269260
703633540314305
804154060359350
904674580403395
1005185100448440

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%2.038.00.05.0%3.057.01.04.9%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%7.013.00.035.0%14.026.00.035.0%17.041.03.027.9%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%1.00.039.02.5%3.00.058.04.9%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%7.013.00.035.0%14.026.00.035.0%17.041.03.027.9%

Fundamentals of Cormedix

About CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

Fundamental data was last updated by Penke on 2024-04-11 05:03:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very efficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of CorMedix Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Cormedix earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Cormedix to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of CorMedix Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-63,476.8%+63,476.8%
TTM-5Y-21,943.6%+21,943.6%
5Y-21,943.6%10Y-22,450.3%+506.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--199.6%+199.6%
TTM--213.0%+213.0%
YOY-63,476.8%-279.3%-63,197.5%
5Y-21,943.6%-438.4%-21,505.2%
10Y-22,450.3%-605.5%-21,844.8%
1.1.2. Return on Assets

Shows how efficient Cormedix is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cormedix to the Biotechnology industry mean.
  • -18.0% Return on Assets means that Cormedix generated $-0.18 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of CorMedix Inc:

  • The MRQ is -18.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is 169.6%. Using its assets, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ-18.0%TTM169.6%-187.6%
TTM169.6%YOY-11.5%+181.1%
TTM169.6%5Y23.8%+145.8%
5Y23.8%10Y-13.4%+37.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-18.0%-13.5%-4.5%
TTM169.6%-12.9%+182.5%
YOY-11.5%-11.8%+0.3%
5Y23.8%-14.1%+37.9%
10Y-13.4%-16.0%+2.6%
1.1.3. Return on Equity

Shows how efficient Cormedix is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cormedix to the Biotechnology industry mean.
  • -21.0% Return on Equity means Cormedix generated $-0.21 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of CorMedix Inc:

  • The MRQ is -21.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -8.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-21.0%TTM-8.2%-12.8%
TTM-8.2%YOY-9.0%+0.8%
TTM-8.2%5Y-10.6%+2.4%
5Y-10.6%10Y-49.8%+39.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-21.0%-16.9%-4.1%
TTM-8.2%-16.1%+7.9%
YOY-9.0%-15.1%+6.1%
5Y-10.6%-19.9%+9.3%
10Y-49.8%-20.9%-28.9%

1.2. Operating Efficiency of CorMedix Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Cormedix is operating .

  • Measures how much profit Cormedix makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cormedix to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of CorMedix Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-65,309.7%+65,309.7%
TTM-5Y-25,280.3%+25,280.3%
5Y-25,280.3%10Y-21,266.8%-4,013.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--295.1%+295.1%
TTM--225.8%+225.8%
YOY-65,309.7%-288.4%-65,021.3%
5Y-25,280.3%-477.4%-24,802.9%
10Y-21,266.8%-625.6%-20,641.2%
1.2.2. Operating Ratio

Measures how efficient Cormedix is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of CorMedix Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY654.097-654.097
TTM-5Y254.024-254.024
5Y254.02410Y214.006+40.018
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.090-3.090
TTM-3.264-3.264
YOY654.0973.783+650.314
5Y254.0245.679+248.345
10Y214.0067.894+206.112

1.3. Liquidity of CorMedix Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Cormedix is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 6.97 means the company has $6.97 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of CorMedix Inc:

  • The MRQ is 6.969. The company is very able to pay all its short-term debts. +2
  • The TTM is 9.530. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.969TTM9.530-2.561
TTM9.530YOY12.044-2.514
TTM9.5305Y10.938-1.407
5Y10.93810Y8.580+2.358
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.9693.914+3.055
TTM9.5304.220+5.310
YOY12.0445.388+6.656
5Y10.9386.045+4.893
10Y8.5806.406+2.174
1.3.2. Quick Ratio

Measures if Cormedix is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Cormedix to the Biotechnology industry mean.
  • A Quick Ratio of 2.84 means the company can pay off $2.84 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of CorMedix Inc:

  • The MRQ is 2.841. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 12.111. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.841TTM12.111-9.270
TTM12.111YOY14.998-2.887
TTM12.1115Y12.859-0.748
5Y12.85910Y10.489+2.370
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8413.572-0.731
TTM12.1113.998+8.113
YOY14.9985.390+9.608
5Y12.8595.969+6.890
10Y10.4896.287+4.202

1.4. Solvency of CorMedix Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Cormedix assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Cormedix to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.15 means that Cormedix assets are financed with 14.5% credit (debt) and the remaining percentage (100% - 14.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of CorMedix Inc:

  • The MRQ is 0.145. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.116. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.145TTM0.116+0.029
TTM0.116YOY0.093+0.023
TTM0.1165Y0.147-0.031
5Y0.14710Y0.355-0.208
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1450.336-0.191
TTM0.1160.334-0.218
YOY0.0930.269-0.176
5Y0.1470.366-0.219
10Y0.3550.390-0.035
1.4.2. Debt to Equity Ratio

Measures if Cormedix is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Cormedix to the Biotechnology industry mean.
  • A Debt to Equity ratio of 17.0% means that company has $0.17 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of CorMedix Inc:

  • The MRQ is 0.170. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.067. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.170TTM0.067+0.103
TTM0.067YOY0.071-0.004
TTM0.0675Y0.115-0.048
5Y0.11510Y0.392-0.277
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1700.382-0.212
TTM0.0670.396-0.329
YOY0.0710.335-0.264
5Y0.1150.434-0.319
10Y0.3920.465-0.073

2. Market Valuation of CorMedix Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Cormedix generates.

  • Above 15 is considered overpriced but always compare Cormedix to the Biotechnology industry mean.
  • A PE ratio of -3.50 means the investor is paying $-3.50 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of CorMedix Inc:

  • The EOD is -4.919. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.503. Based on the earnings, the company is expensive. -2
  • The TTM is -4.773. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.919MRQ-3.503-1.416
MRQ-3.503TTM-4.773+1.270
TTM-4.773YOY-7.679+2.906
TTM-4.7735Y-19.480+14.707
5Y-19.48010Y-11.802-7.678
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.919-2.259-2.660
MRQ-3.503-2.569-0.934
TTM-4.773-2.664-2.109
YOY-7.679-4.120-3.559
5Y-19.480-6.258-13.222
10Y-11.802-6.171-5.631
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of CorMedix Inc:

  • The EOD is -6.573. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.681. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.627. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.573MRQ-4.681-1.892
MRQ-4.681TTM-5.627+0.946
TTM-5.627YOY-9.224+3.597
TTM-5.6275Y21.094-26.721
5Y21.09410Y5.669+15.425
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-6.573-2.924-3.649
MRQ-4.681-3.246-1.435
TTM-5.627-3.488-2.139
YOY-9.224-5.620-3.604
5Y21.094-8.315+29.409
10Y5.669-8.826+14.495
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Cormedix is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.95 means the investor is paying $2.95 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of CorMedix Inc:

  • The EOD is 4.139. Based on the equity, the company is fair priced.
  • The MRQ is 2.947. Based on the equity, the company is underpriced. +1
  • The TTM is 3.532. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD4.139MRQ2.947+1.191
MRQ2.947TTM3.532-0.585
TTM3.532YOY3.897-0.366
TTM3.5325Y9.316-5.784
5Y9.31610Y6.803+2.513
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD4.1391.851+2.288
MRQ2.9472.090+0.857
TTM3.5322.095+1.437
YOY3.8972.844+1.053
5Y9.3163.466+5.850
10Y6.8033.815+2.988
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of CorMedix Inc.

3.1. Institutions holding CorMedix Inc

Institutions are holding 34.198% of the shares of CorMedix Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31BlackRock Inc6.38480.0003350769534903711.0502
2023-12-31Nomura Holdings Inc5.36340.03012946552-4980-0.1687
2023-12-31Vanguard Group Inc5.14270.000228253351745876.5863
2023-12-31Elliott Investment Management L.P.2.82230.0312155052300
2023-12-31Geode Capital Management, LLC2.10930.00051158808785387.2702
2023-12-31State Street Corporation1.95330.0002107313419197521.7866
2023-12-31Marshall Wace Asset Management Ltd0.84280.003463006-451163-49.3523
2023-12-31Northern Trust Corp0.81720.0003448956-2259-0.5006
2023-12-31Millennium Management LLC0.52470.0005288254-85239-22.8221
2023-12-31Morgan Stanley - Brokerage Accounts0.45680.000125097311927290.5627
2023-09-30Citadel Advisors Llc0.44470.0002244307147847153.2729
2023-12-31Nuveen Asset Management, LLC0.43950.00032414818465653.9812
2023-12-31Renaissance Technologies Corp0.4290.0014235700129100121.1069
2023-12-31Barclays PLC0.3980.00032186466631843.5363
2023-12-31Anson Funds Management LP0.36220.09251990001990000
2023-09-30D. E. Shaw & Co LP0.3390.0007186249134945263.0302
2023-12-31Susquehanna International Group, LLP0.33770.0001185534-55209-22.9328
2023-12-31Two Sigma Investments LLC0.32350.0015177738-50871-22.2524
2023-12-31Spinnaker Capital LLC0.319210017538400
2023-12-31Bank of New York Mellon Corp0.29830.0001163891123258.1318
Total 30.1084100.163516541166+1037879+6.3%

3.2. Funds holding CorMedix Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv3.13280.0004172242600
2024-03-28iShares Russell 2000 ETF2.41410.008613273166390.0482
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.39760.002776840000
2024-01-31Fidelity Small Cap Index1.01590.006755853067001.2141
2024-03-28iShares Russell 2000 Growth ETF0.82630.0165454317-528-0.1161
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.62780.002934514457001.6792
2024-02-29Fidelity Extended Market Index0.55380.0028304493-1475-0.4821
2024-03-31State St Russell Sm Cap® Indx SL Cl I0.37210.008920460000
2024-02-29Vanguard Russell 2000 ETF0.36380.0074200046156648.4954
2023-12-31Bridgeway Ultra-Small Company Market0.26950.29991482001500011.2613
2023-12-31NT R2000 Growth Index Fund - NL0.26250.014714435200
2023-12-31NT R2000 Index Fund - NL0.26240.0075144244-6838-4.526
2023-09-30BlackRock Extended Mkt Composite0.24210.00351331204260647.0712
2024-02-29Schwab Small Cap Index0.23410.007712869000
2024-03-28iShares Micro-Cap ETF0.21670.054911914100
2024-03-31BlackRock Extended Equity Market K0.20890.0033114834410.0357
2023-12-31NT R2000 Index Fund - DC - NL - 20.20660.0075113593-5844-4.893
2023-12-31NT R2000 Growth Index Fund - L0.20030.014911011878367.6612
2023-12-31Northern Trust Russell 2000 Growth Index0.20030.01511011878367.6612
2024-02-29Fidelity Total Market Index0.18260.000410040500
Total 13.19020.48627252087+87337+1.2%

3.3. Insider Transactions

Insiders are holding 1.03% of the shares of CorMedix Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-13Joseph TodiscoBUY135613.74
2023-09-08Joseph TodiscoBUY100003.71

4. Summary

4.1. Key Performance Indicators

The key performance indicators of CorMedix Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.1950.069-385%-0.035-82%0.059-430%0.034-680%
Book Value Per Share--1.2761.155+10%1.059+20%0.892+43%0.560+128%
Current Ratio--6.9699.530-27%12.044-42%10.938-36%8.580-19%
Debt To Asset Ratio--0.1450.116+25%0.093+56%0.147-1%0.355-59%
Debt To Equity Ratio--0.1700.067+153%0.071+139%0.115+47%0.392-57%
Dividend Per Share----0%-0%-0%0.000-100%
Eps---0.268-0.209-22%-0.135-50%-0.154-43%-0.133-50%
Free Cash Flow Per Share---0.201-0.175-13%-0.112-44%-0.112-44%-0.098-51%
Free Cash Flow To Equity Per Share---0.1920.074-361%-0.030-84%0.078-348%0.050-488%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0010%
Intrinsic Value_10Y_max---6.484--------
Intrinsic Value_10Y_min---8.168--------
Intrinsic Value_1Y_max---0.431--------
Intrinsic Value_1Y_min---0.574--------
Intrinsic Value_3Y_max---1.463--------
Intrinsic Value_3Y_min---1.946--------
Intrinsic Value_5Y_max---2.694--------
Intrinsic Value_5Y_min---3.552--------
Market Cap290300208.000+29%206728936.000215399373.825-4%227484301.250-9%312569736.415-34%211675302.497-2%
Net Profit Margin----0%-634.7680%-219.4360%-224.5030%
Operating Margin----0%-653.0970%-252.8030%-212.6680%
Operating Ratio----0%654.097-100%254.024-100%214.006-100%
Pb Ratio4.139+29%2.9473.532-17%3.897-24%9.316-68%6.803-57%
Pe Ratio-4.919-40%-3.503-4.773+36%-7.679+119%-19.480+456%-11.802+237%
Price Per Share5.280+29%3.7603.891-3%4.138-9%5.680-34%3.847-2%
Price To Free Cash Flow Ratio-6.573-40%-4.681-5.627+20%-9.224+97%21.094-122%5.669-183%
Price To Total Gains Ratio-27.013-40%-19.237-64.658+236%-49.647+158%-407.295+2017%-199.588+938%
Quick Ratio--2.84112.111-77%14.998-81%12.859-78%10.489-73%
Return On Assets---0.1801.696-111%-0.115-36%0.238-176%-0.134-25%
Return On Equity---0.210-0.082-61%-0.090-57%-0.106-50%-0.498+137%
Total Gains Per Share---0.1950.069-385%-0.035-82%0.059-430%0.034-679%
Usd Book Value--70142429.00064080778.500+9%58244935.250+20%49140395.850+43%30870053.250+127%
Usd Book Value Change Per Share---0.1950.069-385%-0.035-82%0.059-430%0.034-680%
Usd Book Value Per Share--1.2761.155+10%1.059+20%0.892+43%0.560+128%
Usd Dividend Per Share----0%-0%-0%0.000-100%
Usd Eps---0.268-0.209-22%-0.135-50%-0.154-43%-0.133-50%
Usd Free Cash Flow---11041625.000-9684195.000-12%-6144023.000-44%-6153114.750-44%-5418945.375-51%
Usd Free Cash Flow Per Share---0.201-0.175-13%-0.112-44%-0.112-44%-0.098-51%
Usd Free Cash Flow To Equity Per Share---0.1920.074-361%-0.030-84%0.078-348%0.050-488%
Usd Market Cap290300208.000+29%206728936.000215399373.825-4%227484301.250-9%312569736.415-34%211675302.497-2%
Usd Price Per Share5.280+29%3.7603.891-3%4.138-9%5.680-34%3.847-2%
Usd Profit---14754029.00098709443.250-115%-7353762.000-50%14937549.000-199%4390671.300-436%
Usd Revenue----0%16352.000-100%38942.100-100%54036.900-100%
Usd Total Gains Per Share---0.1950.069-385%-0.035-82%0.059-430%0.034-679%
 EOD+5 -3MRQTTM+6 -23YOY+7 -245Y+9 -2210Y+11 -23

4.2. Fundamental Score

Let's check the fundamental score of CorMedix Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.919
Price to Book Ratio (EOD)Between0-14.139
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.841
Current Ratio (MRQ)Greater than16.969
Debt to Asset Ratio (MRQ)Less than10.145
Debt to Equity Ratio (MRQ)Less than10.170
Return on Equity (MRQ)Greater than0.15-0.210
Return on Assets (MRQ)Greater than0.05-0.180
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of CorMedix Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.969
Ma 20Greater thanMa 504.801
Ma 50Greater thanMa 1004.023
Ma 100Greater thanMa 2003.717
OpenGreater thanClose5.500
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets82,060
Total Liabilities11,918
Total Stockholder Equity70,142
 As reported
Total Liabilities 11,918
Total Stockholder Equity+ 70,142
Total Assets = 82,060

Assets

Total Assets82,060
Total Current Assets79,450
Long-term Assets2,610
Total Current Assets
Cash And Cash Equivalents 43,643
Short-term Investments 32,388
Inventory 2,106
Other Current Assets 882
Total Current Assets  (as reported)79,450
Total Current Assets  (calculated)79,019
+/- 431
Long-term Assets
Property Plant Equipment 2,507
Long-term Assets Other 103
Long-term Assets  (as reported)2,610
Long-term Assets  (calculated)2,610
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities11,401
Long-term Liabilities517
Total Stockholder Equity70,142
Total Current Liabilities
Accounts payable 4,280
Total Current Liabilities  (as reported)11,401
Total Current Liabilities  (calculated)4,280
+/- 7,121
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt668
Long-term Liabilities  (as reported)517
Long-term Liabilities  (calculated)668
+/- 151
Total Stockholder Equity
Total Stockholder Equity (as reported)70,142
Total Stockholder Equity (calculated)0
+/- 70,142
Other
Capital Stock55
Common Stock Shares Outstanding 54,938
Net Invested Capital 70,142
Net Working Capital 68,050
Property Plant and Equipment Gross 3,027



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312007-12-31
> Total Assets 
4,113
1,620
0
0
0
2,226
12,070
10,991
9,733
8,848
6,819
4,949
3,031
2,556
2,035
1,036
1,257
1,153
968
395
1,037
2,968
9,761
8,256
6,845
5,098
9,752
38,796
39,307
37,102
33,610
31,213
28,840
21,906
14,933
21,156
13,929
13,454
9,609
5,927
8,049
18,826
27,308
27,559
33,717
29,476
27,400
24,237
40,023
49,308
84,259
80,857
75,389
68,946
64,934
67,748
62,077
62,038
59,234
57,033
91,429
82,060
82,06091,42957,03359,23462,03862,07767,74864,93468,94675,38980,85784,25949,30840,02324,23727,40029,47633,71727,55927,30818,8268,0495,9279,60913,45413,92921,15614,93321,90628,84031,21333,61037,10239,30738,7969,7525,0986,8458,2569,7612,9681,0373959681,1531,2571,0362,0352,5563,0314,9496,8198,8489,73310,99112,0702,2260001,6204,113
   > Total Current Assets 
0
0
0
0
0
1,683
12,016
10,952
9,694
8,812
6,786
4,918
3,003
2,531
2,012
1,000
1,238
1,135
950
378
1,020
2,916
9,714
8,188
6,785
5,038
9,686
38,746
39,261
37,059
33,570
31,176
28,760
21,832
14,865
21,094
13,853
13,268
9,404
5,741
7,870
18,665
27,142
27,413
33,583
29,349
27,281
24,134
38,865
48,182
83,057
79,691
72,991
66,469
62,503
65,359
59,664
59,551
56,781
54,625
89,062
79,450
79,45089,06254,62556,78159,55159,66465,35962,50366,46972,99179,69183,05748,18238,86524,13427,28129,34933,58327,41327,14218,6657,8705,7419,40413,26813,85321,09414,86521,83228,76031,17633,57037,05939,26138,7469,6865,0386,7858,1889,7142,9161,0203789501,1351,2381,0002,0122,5313,0034,9186,7868,8129,69410,95212,0161,68300000
       Cash And Cash Equivalents 
0
1,380
0
0
0
1,505
11,725
10,586
9,522
8,284
6,564
4,738
2,890
1,985
1,855
894
992
835
693
158
483
2,374
9,189
7,652
5,920
4,340
8,799
24,111
14,247
11,817
13,185
12,021
9,827
8,064
6,819
7,937
5,213
10,380
8,162
4,702
6,444
17,624
18,257
14,733
20,145
16,525
12,205
16,494
34,365
42,097
76,215
73,093
66,316
53,551
45,389
48,930
43,254
43,375
25,497
19,889
53,314
43,643
43,64353,31419,88925,49743,37543,25448,93045,38953,55166,31673,09376,21542,09734,36516,49412,20516,52520,14514,73318,25717,6246,4444,7028,16210,3805,2137,9376,8198,0649,82712,02113,18511,81714,24724,1118,7994,3405,9207,6529,1892,3744831586938359928941,8551,9852,8904,7386,5648,2849,52210,58611,7251,5050001,3800
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
220
221
221
0
0
0
132
13,377
23,605
23,568
17,044
16,591
16,827
12,101
6,951
10,884
6,796
1,604
1,604
172
172
0
7,945
11,825
12,294
11,984
10,983
5,948
2,675
4,444
4,957
5,159
5,653
12,149
16,298
15,693
15,746
15,644
30,332
32,701
33,273
32,388
32,38833,27332,70130,33215,64415,74615,69316,29812,1495,6535,1594,9574,4442,6755,94810,98311,98412,29411,8257,94501721721,6041,6046,79610,8846,95112,10116,82716,59117,04423,56823,60513,37713200022122122000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
494
494
0
0
0
0
0
0
2
14
55
46
80
69
113
125
316
345
6
22
12
76
154
89
64
9
3
302
11
34
-172
4
0
7
11
6
3
44
3
0
45
3
0
0
0
0
0
0
0
000000034503443611704-17234113023964891547612226345316125113698046551420000004944940000000000000
       Inventory 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
271
80
64
278
677
463
461
715
699
377
334
158
118
167
95
313
299
594
579
673
341
429
420
403
381
338
295
278
201
144
85
73
49
3
3
2
0
0
0
0
0
2,106
2,1060000023349738514420127829533838140342042934167357959429931395167118158334377699715461463677278648027100000000000000000000
   > Long-term Assets 
0
0
0
0
0
542
53
39
39
36
33
31
28
25
23
37
20
18
17
17
16
52
47
68
60
60
65
50
46
43
40
37
81
75
68
62
76
186
205
186
178
161
166
147
135
127
119
103
1,157
1,126
1,202
1,167
2,399
2,477
2,430
2,389
2,413
2,487
2,452
2,408
2,367
2,610
2,6102,3672,4082,4522,4872,4132,3892,4302,4772,3991,1671,2021,1261,1571031191271351471661611781862051867662687581374043465065606068475216171718203723252831333639395354200000
       Property Plant Equipment 
44
34
0
0
0
24
28
25
26
22
19
18
15
12
10
8
6
5
4
4
3
36
34
54
47
41
47
45
41
38
35
32
76
70
63
57
71
186
205
186
178
161
166
147
135
127
119
103
1,157
1,126
1,099
1,064
2,296
2,374
2,328
2,286
2,310
2,385
2,350
2,306
2,264
2,507
2,5072,2642,3062,3502,3852,3102,2862,3282,3742,2961,0641,0991,1261,15710311912713514716616117818620518671576370763235384145474147543436344568101215181922262528240003444
       Long-term Assets Other 
0
0
0
0
0
507
0
0
0
0
0
13
13
13
13
15
13
13
13
13
13
16
13
13
13
18
18
5
5
5
5
5
5
5
5
5
5
0
0
0
0
0
166
147
135
127
119
0
1,042
1,015
102
102
102
102
102
102
102
102
-30,302,058
102
103
103
103103102-30,302,0581021021021021021021021021,0151,0420119127135147166000005555555555181813131316131313131315131313130000050700000
> Total Liabilities 
0
13,647
0
0
0
16,935
1,421
1,171
956
1,592
1,459
1,715
2,293
1,319
1,612
1,180
1,374
1,629
2,244
2,589
3,945
6,990
13,490
9,856
1,267
1,463
2,156
1,945
2,915
3,090
3,090
3,142
5,061
4,092
3,890
5,790
4,252
6,261
8,768
12,405
17,546
13,892
10,766
11,084
5,010
5,830
5,806
5,716
5,553
5,085
3,944
3,988
6,045
6,148
5,064
6,009
5,765
6,979
5,306
7,982
8,227
11,918
11,9188,2277,9825,3066,9795,7656,0095,0646,1486,0453,9883,9445,0855,5535,7165,8065,8305,01011,08410,76613,89217,54612,4058,7686,2614,2525,7903,8904,0925,0613,1423,0903,0902,9151,9452,1561,4631,2679,85613,4906,9903,9452,5892,2441,6291,3741,1801,6121,3192,2931,7151,4591,5929561,1711,42116,93500013,6470
   > Total Current Liabilities 
1,212
13,647
0
0
0
16,935
1,421
1,152
938
1,576
1,443
1,700
2,278
1,305
1,598
1,166
1,362
1,616
2,233
2,579
3,937
1,674
1,122
1,181
1,227
1,425
2,120
1,912
2,882
3,061
3,064
3,118
5,039
4,092
3,890
5,790
4,252
6,261
8,768
12,405
17,546
7,766
4,335
4,346
5,007
5,827
5,804
5,714
4,601
4,162
3,049
3,123
5,211
5,345
4,294
5,272
5,062
6,311
4,675
7,387
7,671
11,401
11,4017,6717,3874,6756,3115,0625,2724,2945,3455,2113,1233,0494,1624,6015,7145,8045,8275,0074,3464,3357,76617,54612,4058,7686,2614,2525,7903,8904,0925,0393,1183,0643,0612,8821,9122,1201,4251,2271,1811,1221,6743,9372,5792,2331,6161,3621,1661,5981,3052,2781,7001,4431,5769381,1521,42116,93500013,6471,212
       Short-term Debt 
0
0
0
0
0
13,765
0
0
0
0
0
0
0
0
0
0
168
270
599
696
1,535
0
0
0
0
0
0
66
70
67
71
1
3
2
13
2,042
0
0
0
0
0
0
2
0
0
0
0
0
98
109
112
116
118
121
124
127
131
135
139
143
147
0
0147143139135131127124121118116112109980000020000002,04213231716770660000001,535696599270168000000000013,76500000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,880
0
0
0
0
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000020000001,88000000000000000000000000000000000000
       Accounts payable 
1,212
822
0
0
0
550
1,046
804
517
1,139
1,294
1,437
990
1,008
1,425
994
918
1,024
1,312
1,489
970
940
1,027
849
740
893
1,429
1,142
1,425
1,709
1,581
1,109
1,758
1,645
1,726
1,766
1,408
1,808
3,660
7,309
7,882
2,589
1,462
906
1,055
1,024
1,333
1,386
1,986
1,128
1,500
943
1,107
2,210
1,740
2,496
1,767
2,202
1,447
2,901
2,386
4,280
4,2802,3862,9011,4472,2021,7672,4961,7402,2101,1079431,5001,1281,9861,3861,3331,0241,0559061,4622,5897,8827,3093,6601,8081,4081,7661,7261,6451,7581,1091,5811,7091,4251,1421,4298937408491,0279409701,4891,3121,0249189941,4251,0089901,4371,2941,1395178041,0465500008221,212
       Other Current Liabilities 
0
1,172
0
0
0
2,620
375
348
421
436
149
263
1,288
297
174
173
276
323
322
394
583
734
95
332
478
523
682
695
1,380
1,154
1,276
1,876
3,146
2,341
2,050
1,880
2,758
4,364
5,091
5,080
9,651
5,166
2,864
3,434
3,947
4,800
4,471
4,328
2,517
2,924
1,437
2,064
3,986
3,014
2,430
2,649
3,163
3,974
3,089
4,344
5,138
0
05,1384,3443,0893,9743,1632,6492,4303,0143,9862,0641,4372,9242,5174,3284,4714,8003,9473,4342,8645,1669,6515,0805,0914,3642,7581,8802,0502,3413,1461,8761,2761,1541,380695682523478332957345833943223232761731742971,2882631494364213483752,6200001,1720
   > Long-term Liabilities 
0
0
0
0
0
0
0
19
18
17
16
16
15
14
14
13
13
12
11
10
8
5,316
12,368
8,676
40
38
36
33
33
29
27
24
22
0
0
0
0
0
0
0
0
6,125
6,431
6,738
3
3
2
2
952
924
894
864
834
802
770
737
703
668
631
594
556
517
51755659463166870373777080283486489492495222336,7386,4316,125000000002224272933333638408,67612,3685,3168101112131314141516161718190000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,125
6,427
6,734
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000006,7346,4276,12500000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
-13,765
0
0
0
0
0
0
0
0
0
0
-168
-270
-599
-696
-1,535
0
0
0
0
0
0
-66
-70
-67
-71
-1
-3
-2
-13
-2,042
0
0
0
0
0
0
2
3
3
3
2
2
952
924
894
864
834
802
770
737
703
668
631
594
556
668
668556594631668703737770802834864894924952223332000000-2,042-13-2-3-1-71-67-70-66000000-1,535-696-599-270-1680000000000-13,76500000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
3
3
3
2
2
952
924
894
864
834
802
770
737
703
0
631
594
0
0
005946310703737770802834864894924952223334000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
16
15
14
14
13
13
12
11
10
8
5,316
12,368
8,676
40
38
36
33
33
29
27
24
22
29
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000292224272933333638408,67612,3685,316810111213131414151600000000000
> Total Stockholder Equity
0
0
0
0
0
-14,709
10,649
9,820
8,777
7,255
5,360
3,234
738
1,237
423
-143
-117
-475
-1,276
-2,194
-2,909
-4,022
-3,729
-1,601
5,578
3,634
7,596
36,851
36,392
34,011
30,519
28,071
23,779
17,815
11,043
15,366
9,676
-152,175
841
-6,478
-9,498
-178,988
16,542
-184,852
28,708
-195,421
21,593
18,521
34,469
-217,449
80,315
76,870
69,344
-245,659
59,869
61,739
56,312
-275,361
-285,928
-297,202
83,202
70,142
70,14283,202-297,202-285,928-275,36156,31261,73959,869-245,65969,34476,87080,315-217,44934,46918,52121,593-195,42128,708-184,85216,542-178,988-9,498-6,478841-152,1759,67615,36611,04317,81523,77928,07130,51934,01136,39236,8517,5963,6345,578-1,601-3,729-4,022-2,909-2,194-1,276-475-117-1434231,2377383,2345,3607,2558,7779,82010,649-14,70900000
   Retained Earnings -321,700-306,946-297,202-285,928-275,361-267,152-260,298-252,693-245,659-237,868-229,299-224,666-217,449-211,362-204,761-200,979-195,421-190,117-184,852-184,156-178,988-181,136-170,900-162,342-152,175-141,864-131,908-126,762-119,165-112,636-103,510-98,623-94,392-90,525-85,837-81,702-76,204-73,990-68,955-72,491-55,751-52,464-49,772-47,811-46,373-45,185-44,482-43,858-42,948-43,288-40,688-38,211-36,236-34,733-33,341-32,168-25,33100000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
-26
0
0
0
-38
-38
0
0
0
0
0
0
-57
-57
0
0
-9
-11
-1
117
99
102
93
100
62
93
90
83
81
90
97
95
98
97
97
91
97
95
104
102
97
91
106
100
102
99
99
96
87
50
40
46
83
101
91
84
0
084911018346405087969999102100106919710210495979197979895979081839093621009310299117-1-11-900-57-57000000-38-38000-2600000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
43,912
44,015
44,173
44,269
44,327
45,057
45,887
46,652
47,694
49,539
51,720
68,750
67,332
79,427
79,716
89,168
122,560
126,781
128,305
129,012
131,452
136,291
136,857
137,674
147,117
151,384
159,198
163,004
164,239
171,449
183,717
200,579
201,199
218,697
218,944
222,455
223,151
245,700
261,536
304,844
306,031
307,079
308,332
312,474
321,956
323,377
0
339,710
346,116
0
0
00346,116339,7100323,377321,956312,474308,332307,079306,031304,844261,536245,700223,151222,455218,944218,697201,199200,579183,717171,449164,239163,004159,198151,384147,117137,674136,857136,291131,452129,012128,305126,781122,56089,16879,71679,42767,33268,75051,72049,53947,69446,65245,88745,05744,32744,26944,17344,01543,91200000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000-1-1



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-48,958
Operating Income-48,958-48,958
 
Operating Expense (+$)
Research Development13,155
Selling General Administrative35,803
Selling And Marketing Expenses0
Operating Expense48,95848,958
 
Net Interest Income (+$)
Interest Income2,682
Interest Expense-34
Other Finance Cost-0
Net Interest Income2,648
 
Pretax Income (+$)
Operating Income-48,958
Net Interest Income2,648
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-46,339-48,929
EBIT - interestExpense = -34
-46,339
-46,305
Interest Expense34
Earnings Before Interest and Taxes (EBIT)0-46,305
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-46,339
Tax Provision-0
Net Income From Continuing Ops-46,339-46,339
Net Income-46,339
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net-29-2,648
 

Technical Analysis of Cormedix
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Cormedix. The general trend of Cormedix is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Cormedix's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of CorMedix Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 7 < 8.025.

The bearish price targets are: 4.55 > 4.48 > 4.4.

Tweet this
CorMedix Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of CorMedix Inc. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

CorMedix Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of CorMedix Inc. The current macd is 0.45416527.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Cormedix price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Cormedix. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Cormedix price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
CorMedix Inc Daily Moving Average Convergence/Divergence (MACD) ChartCorMedix Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of CorMedix Inc. The current adx is 44.11.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Cormedix shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
CorMedix Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of CorMedix Inc. The current sar is 6.88944096.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
CorMedix Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of CorMedix Inc. The current rsi is 60.97. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
CorMedix Inc Daily Relative Strength Index (RSI) ChartCorMedix Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of CorMedix Inc. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Cormedix price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
CorMedix Inc Daily Stochastic Oscillator ChartCorMedix Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of CorMedix Inc. The current cci is 78.75.

CorMedix Inc Daily Commodity Channel Index (CCI) ChartCorMedix Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of CorMedix Inc. The current cmo is 15.46.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
CorMedix Inc Daily Chande Momentum Oscillator (CMO) ChartCorMedix Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of CorMedix Inc. The current willr is -58.30508475.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Cormedix is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
CorMedix Inc Daily Williams %R ChartCorMedix Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of CorMedix Inc.

CorMedix Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of CorMedix Inc. The current atr is 0.46358317.

CorMedix Inc Daily Average True Range (ATR) ChartCorMedix Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of CorMedix Inc. The current obv is -4,443,889.

CorMedix Inc Daily On-Balance Volume (OBV) ChartCorMedix Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of CorMedix Inc. The current mfi is 82.74.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
CorMedix Inc Daily Money Flow Index (MFI) ChartCorMedix Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for CorMedix Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-16WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-14ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-05ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-11ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19MFI LONG ENTRY SHORT CLOSE80 crossover to upside

6.3. Candlestick Patterns

CorMedix Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of CorMedix Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.969
Ma 20Greater thanMa 504.801
Ma 50Greater thanMa 1004.023
Ma 100Greater thanMa 2003.717
OpenGreater thanClose5.500
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Cormedix with someone you think should read this too:
  • Are you bullish or bearish on Cormedix? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Cormedix? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about CorMedix Inc

I send you an email if I find something interesting about CorMedix Inc.


Comments

How you think about this?

Leave a comment

Stay informed about CorMedix Inc.

Receive notifications about CorMedix Inc in your mailbox!